Drugs / AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION

Trials 5 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT04312113 Nov 2020 → Oct 2026 expected ulcerative colitis Mayo Clinic Active not recruiting No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT04750252 Oct 2025 → Aug 2027 expected osteoarthritis, knee Akan Biosciences, LLC Not yet recruiting No outcome recorded
Phase 22 trials
Phase 2 NCT05385159 Sep 2022 → Jun 2024 Assistance Publique Hopitaux De Marseille Unknown No outcome recorded
Phase 2 NCT05264922 Jan → Jul 2022 rotator cuff syndrome AdventHealth Withdrawn No outcome recorded
Phase not applicable1 trial
NCT07487467 Jan 2025 → Mar 2026 overdue type 2 diabetes mellitus Kaiser Clinic and Hospital Recruiting No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Autologous Adipose-Derived Stromal Vascular Fraction ClinicalTrials.gov intervention name — accepted as the source's own label NCT07487467
1

NCT05385159

Known as Adipose derived, autologous mesenchymal stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT04312113
Known as ADSVF “Autologous Adipose-Derived Stromal Vascular Fraction (ADSVF) is recognized as an easily accessible source of cells displaying angiogenic, anti-inflammatory, immunomodulatory...” NCT05385159
Known as Stromal Vascular Fraction Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT05264922
Known as StroMel ClinicalTrials.gov intervention name — accepted as the source's own label NCT04750252
Known as SVF “Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears” NCT05264922
1

“Autologous Adipose-Derived Stromal Vascular Fraction (SVF)” NCT07487467

Modality Cell therapy “adipose derived mesenchymal stem cell (MSC)” NCT04312113
Route Other “autologous ADSVF local injections” NCT05385159